Test Country
Filter by Category
This field is for validation purposes and should be left unchanged.

Showing 11–20 of 43 results

CBC, Path Review

Code
CT331
Results
1-3 days.
Country
CA
Specimen
1.0 mL EDTA whole blood in lavender top tube
Description
CBC, clinical pathologist review of blood smear and results

This includes WBC, RBC, HGB, HCT, MCV, MCH, MCHC, platelet count and estimate, WBC differential, RBC, and WBC morphology. A clinical pathologist will then review results and blood smears and provide an interpretative comment of the complete blood count.

Interferences: marked hemolysis and lipemia.

CBC/Reticulocyte

Code
CT337
Results
Daily. Performed each shift
Country
CA
Specimen
1.0 mL EDTA whole blood in lavender top tube
Description
CBC, Reticulocyte Count

This includes WBC, RBC, HGB, HCT, MCV, MCH, MCHC, platelet count and estimate, WBC differential, RBC, and WBC morphology (T330) and a reticulocyte count (T425).

Interferences: marked hemolysis and lipemia.

Coagulation Panel with D-Dimer

Code
SA290
Results
24 hours. Performed each shift
Country
US
Container
Lavender top, citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
CBC, PT and aPTT, Fibrinogen (Quantitative), and D-Dimer

Panel used to evaluate a patient exhibiting unexplained bleeding and/or thromboembolic disorders. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes a CBC, PT/PTT, fibrinogen and D-dimer.

Interferences: marked hemolysis, lipemia or clotting.

Coagulation Profile 1

Code
CSA290
Results
Daily. Performed each shift
Country
CA
Container
Lavender top, citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
CBC, PT and aPTT, Fibrinogen Quantitative, and D-Dimer

Panel used to evaluate a patient exhibiting unexplained bleeding and/or thromboembolic disorders. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes a CBC, PT/PTT, fibrinogen and D-dimer.

Interferences: marked hemolysis, lipemia or clotting.

Coagulation Profile 2

Code
SA300
Results
24 hours. Performed each shift
Country
US
Container
Lavender top, citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
PT and aPTT, Fibrinogen (Quantitative), D-Dimer, and Platelet Count

Panel used to evaluate a patient exhibiting unexplained bleeding and/or thromboembolic disorders. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes PT/PTT, platelet count, fibrinogen and D- dimer.

Interferences: marked hemolysis, lipemia or clotting.

Coagulation Profile 2

Code
CSA300
Results
Daily. Performed each shift
Country
CA
Container
Lavender top, citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
PT and aPTT, Fibrinogen (Quantitativ), D-Dimer, and Platelet Count

Panel used to evaluate a patient exhibiting unexplained bleeding and/or thromboembolic disorders. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes PT/PTT, platelet count, fibrinogen and D- dimer.

Interferences: marked hemolysis, lipemia or clotting.

Coagulation Profile 3

Code
CSA305
Results
Daily. Performed each shift
Country
CA
Container
Citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
PT and aPTT, and Platelet Count

Panel used to evaluate a patient exhibiting unexplained bleeding. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes PT/PTT and platelet count.

Interferences: marked hemolysis, marked lipemia or clotting.

Coagulation Profile 3

Code
SA305
Results
24 hours. Performed each shift
Country
US
Container
Lavender top, citrated plasma (or filled blue top)
Specimen
1.0 mL EDTA whole blood and 1.0 mL citrated plasma
Description
PT and aPTT, and Platelet Count

Panel used to evaluate a patient exhibiting unexplained bleeding. Additionally, it can be used to evaluate risk of bleeding secondary to provocative procedures. Includes PT/PTT and platelet count.

Interferences: marked hemolysis, marked lipemia or clotting.

Complete Blood Count

Code
CT330
Results
Daily. Performed each shift
Country
CA
Specimen
1.0 mL EDTA whole blood in lavender top tube
Description
Includes WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, Platelet count and Differential: Percent and Absolute Neutrophils, Bands, Lymphocytes, Monocytes, Eosinophils, Basophils

Includes WBC, RBC, HGB, HCT, MCV, MCH, MCHC, platelet count and estimate, WBC differential, RBC and WBC morphology.

Interferences: marked hemolysis and lipemia.

Complete Blood Count

Code
T330
Results
24 hours. Performed each shift
Country
US
Specimen
1.0 mL EDTA whole blood in lavender top tube
Description
Includes WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, Platelet count and Differential: Percent and Absolute Neutrophils, Bands, Lymphocytes, Monocytes, Eosinophils, Basophils

Includes WBC, RBC, HGB, HCT, MCV, MCH, MCHC, platelet count and estimate, WBC differential, RBC and WBC morphology.

Interferences: marked hemolysis and lipemia.

Test Request Forms

As a service to our valued clients, Antech provides quick online access to test request forms in PDF format. Click download on the desired form below and the PDF will open in a new window, where you have the option to save or print.

COHW

Canine Occult Heartworm Multi-Test

Form 7

Equine Histopathology/Cytology

Compare Tests (0 of 5)

×